⌘K

Login Start Free

Home/Filings/3/0001225208-21-012492

3//SEC Filing

PF Equity Holdings 2 B.V. 3

Accession 0001225208-21-012492

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 6:25 PM ET

Size

7.9 KB

Accession

0001225208-21-012492

Insider Transaction Report

Form 3

Period: 2021-09-10

Allogene Therapeutics, Inc.ALLO

PF Equity Holdings 2 B.V.

10% Owner

Holdings

Common Stock
22,032,040

Footnotes (1)

[F1]Shares acquired from its parent entity, Pfizer Inc. for no cash consideration.

Documents

2 files

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

IncorporatedNetherlands

Related Parties

1

filerCIK 0001883111

Filing Metadata

Form type: 3
Filed: Sep 19, 8:00 PM ET
Accepted: Sep 20, 6:25 PM ET
Size: 7.9 KB

View on SEC.gov